The fintech firm Nukkleus said on Thursday that it has regained compliance with the market value of listed securities requirement as outlined in Nasdaq Listing Rules and the market value of publicly held shares requirement as outlined in the rules.
As a result, Nasdaq has officially canceled the hearing scheduled for January 21, 2025, confirming that Nukkleus's securities will continue to be listed and traded on The Nasdaq Stock Market.
Nukkleus shares jumped 90% in premarket trading Friday.